Evaluation of Iodine Supplementation in Women With Pregnancy Associated With Gestational Diabetes. IODIAB Study

Abstract Iodine supplementation is indicated by the French High Authority for Health (HAS) and by the World Health Organization (WHO) during pregnancy. We want to know if this supplementation is prescribed in a manner consistent with the HAS and WHO recommenations in women diagnosed with gestational diabetes mellitus.Results: Recruitment for the study will start August 2021 and will be ended in October 2021, with the final study results scheduled for December 2021Conclusion The objective of the Iododiab study is to assess whether practitioners caring for women with gestational diabetes mellitus prescribe iodine supplementation according to the recommendations of the French High Authority for Health and by the World Health Organization.